World's Best Scientists 2026 revealed!
Award Badge
Biology and Biochemistry
Switzerland
2023

D-Index & Metrics

Biology and Biochemistry

D-Index
104
Citations
39626
World Ranking
1254
National Ranking
28

Doriano Fabbro publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Doriano Fabbro sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 314 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Doriano Fabbro D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Doriano Fabbro sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 104 D-Index — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Biology and Biochemistry in Switzerland Leader Award

Overview

Doriano Fabbro is affiliated with Novartis in Switzerland and has a research focus concentrated primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work spans numerous subfields including Molecular Biology, Organic Chemistry, Immunology, Genetics, and Pathology and Forensic Medicine.

The main research topics covered by Doriano Fabbro include:

  • PI3K/AKT/mTOR signaling in cancer
  • Cancer Mechanisms and Therapy
  • Chronic Myeloid Leukemia Treatments
  • Chronic Lymphocytic Leukemia Research
  • Quinazolinone synthesis and applications
  • Enzyme function and inhibition
  • Synthesis and biological activity

Frequent collaborators in their publications are:

  • S P H Alexander
  • Elena Faccenda
  • Simon D Harding
  • Jamie A. Davies
  • Eamonn Kelly

Doriano Fabbro's research output appears notably in several journals, with multiple publications in the following venues:

  • British Journal of Pharmacology
  • Nature Reviews Drug Discovery
  • Journal of Medicinal Chemistry
  • Neuropharmacology
  • International Journal of Molecular Sciences

Recent significant publications include:

  • "Trends in kinase drug discovery: targets, indications and inhibitor design," 2021, Nature Reviews Drug Discovery
  • "THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes," 2021, British Journal of Pharmacology
  • "The Concise Guide to PHARMACOLOGY 2023/24: Enzymes," 2023, British Journal of Pharmacology
  • "THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets," 2021, British Journal of Pharmacology
  • "The Concise Guide to PHARMACOLOGY 2023/24: Introduction and Other Protein Targets," 2023, British Journal of Pharmacology

Best Publications

  • Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl

    Ellen Weisberg;Paul W. Manley;Werner Breitenstein;Josef Brüggen

  • The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY

    Simon D. Harding;Joanna L. Sharman;Elena Faccenda;Christopher Southan

  • Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity

    Sauveur-Michel Maira;Frédéric Stauffer;Josef Brueggen;Pascal Furet

  • The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands

    Christopher Southan;Joanna L. Sharman;Helen E. Benson;Elena Faccenda

  • A Novel Antisense Oligonucleotide Targeting Survivin Expression Induces Apoptosis and Sensitizes Lung Cancer Cells to Chemotherapy

    R A Olie;A P Simões-Wüst;B Baumann;S H Leech

  • Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412.

    Ellen Weisberg;Christina Boulton;Louise M Kelly;Paul Manley

  • Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C- raf kinase

    Brett P. Monia;Joseph F. Johnston;Thomas Geiger;Marcel Muller

  • PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid.

    Gertraud Müller;Mohamed Ayoub;Peter Storz;Jörg Rennecke

  • In vivo antitumor activity of NVP-AEW541—A novel, potent, and selective inhibitor of the IGF-IR kinase

    Carlos Garcia-Echeverria;Mark Andrew Pearson;Andreas Marti;Thomas Meyer

  • THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes

    Stephen P.H. Alexander;Doriano Fabbro;Eamonn Kelly;Neil V. Marrion

  • Identification and Characterization of NVP-BKM120, an Orally Available Pan-Class I PI3-Kinase Inhibitor

    Sauveur-Michel Maira;Sabina Pecchi;Alan Huang;Matthew Burger

  • The Concise Guide to PHARMACOLOGY 2015/16: Enzymes

    Stephen P. H. Alexander;Doriano Fabbro;Eamonn Kelly;Neil Marrion

  • A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and In vitro anti‐proliferative as well as In vivo anti‐tumor activity

    T Meyer;U Regenass;D Fabbro;E Alteri

  • Trends in kinase drug discovery: targets, indications and inhibitor design.

    Misty M. Attwood;Doriano Fabbro;Aleksandr V. Sokolov;Stefan Knapp;Stefan Knapp

  • The Concise Guide to PHARMACOLOGY 2017/18: Overview

    Stephen P. H. Alexander;Eamonn Kelly;Neil V. Marrion;John A. Peters

  • Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia.

    Yiguo Hu;Yuhua Liu;Shawn Pelletier;Elisabeth Buchdunger

  • AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.

    Peter Traxler;Peter Roland Allegrini;Ralf Brandt;Josef Brueggen

  • THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes.

    Stephen P H Alexander;Doriano Fabbro;Eamonn Kelly;Alistair Mathie

  • The Crystal Structure of a c-Src Complex in an Active Conformation Suggests Possible Steps in c-Src Activation

    Sandra W. Cowan-Jacob;Gabriele Fendrich;Paul W. Manley;Wolfgang Jahnke

  • Allosteric inhibitors of Bcr-abl–dependent cell proliferation

    Francisco J Adrián;Qiang Ding;Taebo Sim;Anastasia Velentza

Frequent Co-Authors

Pascal Furet
Pascal Furet Novartis (Switzerland)
Matthias P. Wymann
Matthias P. Wymann University of Basel
James D. Griffin
James D. Griffin Harvard University
Jamie A. Davies
Jamie A. Davies University of Edinburgh
Stephen P.H. Alexander
Stephen P.H. Alexander University of Nottingham
Francesco Bertoni
Francesco Bertoni Institute of Oncology Research
Emanuele Zucca
Emanuele Zucca Universita della Svizzera Italiana
Christoph Borner
Christoph Borner University of Freiburg
Josef Pfeilschifter
Josef Pfeilschifter Goethe University Frankfurt
Romano Regazzi
Romano Regazzi University of Lausanne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Doriano Fabbro

Trending Scientists

Recently Published Articles